-
INFIQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Infinity Pharmaceuticals (INFIQ)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 17.90 mm | 17.90 mm | 17.90 mm | 17.90 mm | 17.90 mm | 17.90 mm |
Cash burn (monthly) | 2.66 mm | 2.34 mm | 3.37 mm | 3.50 mm | 2.67 mm | 3.24 mm |
Cash used (since last report) | 47.46 mm | 41.71 mm | 60.10 mm | 62.42 mm | 47.55 mm | 57.73 mm |
Cash remaining | -29.55 mm | -23.80 mm | -42.20 mm | -44.52 mm | -29.65 mm | -39.83 mm |
Runway (months of cash) | -11.1 | -10.2 | -12.5 | -12.7 | -11.1 | -12.3 |
13F holders | Current |
---|---|
Total holders | 48 |
Opened positions | 3 |
Closed positions | 9 |
Increased positions | 8 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 4.10 bn |
Total shares | 27.19 mm |
Total puts | 20.10 k |
Total calls | 74.90 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Biotechnology Value Fund L P | 6.35 mm | $0.00 |
BVF | 6.35 mm | $1.34 bn |
Vanguard | 3.98 mm | $838.18 mm |
Sphera Funds Management | 1.48 mm | $310.70 mm |
BLK BlackRock | 1.46 mm | $307.73 mm |
Carlson Capital L P | 1.30 mm | $273.65 mm |
Mariner | 1.20 mm | $252.00 mm |
Geode Capital Management | 807.52 k | $169.98 mm |
Integrated Core Strategies | 743.27 k | $1.67 mm |
Ergoteles | 696.51 k | $146.62 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Sep 23 | Adelene Q Perkins | Common Stock | Sell | Dispose S | No | Yes | 0.07 | 410,196 | 28.71 k | 1,175,291 |
9 Sep 23 | Adelene Q Perkins | Common Stock | Option exercise | Acquire M | No | No | 0 | 768,133 | 0.00 | 1,585,487 |
9 Sep 23 | Adelene Q Perkins | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 768,133 | 0.00 | 0 |